U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07748026) titled 'A Study of ART105 in Healthy Adult Participants' on July 25.
Brief Summary: The goal of this clinical trial is to learn if ART105 is safe in healthy adult participants. It will also learn about the PK and PD profiles of ART105. The main questions it aims to answer are:
Is ART105 safe and tolerable in adult participants? How does the ART105 influence the urine PC1 level of participants?
Participants will:
recieve single dose of ART105 and visit the clinic 3 months
Study Start Date: Aug. 03
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: ART105
injection
DRUG: Placebo
injection
Recruitment Status: NOT_YET...